Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 8,356,000 | 5,523,000 | 4,015,700 | 3,629,400 | 3,340,100 |
| Cost of Goods | 1,341,000 | 736,000 | 443,000 | 408,400 | 402,100 |
| Gross Profit | 7,015,000 | 4,787,000 | 3,572,700 | 3,221,000 | 2,938,000 |
| Operating Expenses | 3,924,000 | 5,572,000 | 2,041,500 | 1,677,400 | 1,445,000 |
| Operating Income | 3,091,000 | -785,000 | 1,531,200 | 1,544,000 | 1,493,100 |
| Interest Expense | 31,000 | 44,000 | 13,600 | 15,900 | 15,200 |
| Other Income | 113,000 | 144,000 | 168,700 | 146,200 | 88,300 |
| Pre-tax Income | 3,173,000 | -685,000 | 1,686,300 | 1,674,300 | 1,566,200 |
| Income Tax | 914,000 | 707,000 | 566,600 | 535,800 | 469,800 |
| Net Income Continuous | 2,259,000 | -1,392,000 | 1,119,700 | 1,138,500 | 1,096,400 |
| Net Income | $2,259,000 | $-1,392,000 | $1,119,700 | $1,138,500 | $1,096,400 |
| EPS Basic Total Ops | 1.75 | -1.21 | 1.07 | 1.11 | 1.07 |
| EPS Basic Continuous Ops | 1.75 | -1.21 | 1.07 | 1.11 | 1.07 |
| EPS Diluted Total Ops | 1.69 | -1.21 | 1.03 | 1.05 | 1.02 |
| EPS Diluted Continuous Ops | 1.68 | -1.21 | 1.03 | 1.05 | 1.02 |
| EBITDA(a) | $3,778,000 | $-338,000 | $1,797,100 | $1,755,800 | $1,669,900 |